Similar Items: Correction: Salivary and serum interleukin-17A and interleukin-18 levels in patients with type 2 diabetes mellitus with and without periodontitis
- Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
- Molecular Evaluation of Interleukin-8, Interleukin-27, and Vascular Endothelial Growth Factor Expression in Prostate Cancer Patients
- Genetic ablation of interleukin-17A augments fibrosis in a mouse model of cholestatic liver injury
- Correction to “Complement 3 Mediates Periodontal Destruction in Patients With Type 2 Diabetes by Regulating Macrophage Polarization in Periodontal Tissues”
- Assessment of Interleukin-31 and Calprotectin in Immunocompromised Patients with Epstein-Barr Virus Infection
- Immunological Impact of Calprotectin and Interleukin-34 in Immunocompromised Patients with Chronic Cytomegalovirus Infection